CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating activities:
Consolidated net loss	$ (28,378)	$ (27,630)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	13,791	14,179
Employee stock compensation expense	1,382	1,770
Changes in deferred taxes	(2,337)	(2,802)
Provision for expected credit losses	383	(453)
Amortization of debt issuance costs and original issue discount	1,404	1,288
Non-cash interest and accretion expense	2,718	3,076
Other non-cash operating activities	(39)	643
Changes in operating assets and liabilities:
Trade receivables and contract assets	14,686	3,391
Inventories	1,414	(13,632)
Prepaid expenses and other current assets	12,304	19,606
Operating lease right-of-use assets and liabilities, net	221	(353)
Accounts payable	(4,230)	(7,240)
Accrued expenses and other current liabilities	(3,620)	(2,343)
Fees invoiced in advance	(14,479)	5,071
Other asset and liabilities, net	(653)	932
Net cash used in operating activities	(5,433)	(4,497)
Investing activities:
Capital expenditures	(5,180)	(4,459)
Net cash used in investing activities	(5,180)	(4,459)
Financing activities:
Payments on revolving credit facility	0	(20,000)
Payments on senior term notes and delayed draw term loans	(1,428)	(691)
Borrowings on revolving credit facility	3,000	20,000
Issuance of common shares	0	27,524
Other financing activities, net	(36)	(708)
Net cash provided by financing activities	1,536	26,125
Effect of exchange rate changes on cash and cash equivalents	68	(558)
Net (decrease) increase in cash and cash equivalents	(9,009)	16,611
Cash and cash equivalents at beginning of period	21,741	21,432
Cash and cash equivalents at end of period	12,732	38,043
Supplemental disclosure of cash flow information:
Cash paid for interest	9,685	10,888
Income taxes paid, net	$ 827	$ 271